This document is an excerpt from the EUR-Lex website
Document 02007D0782-20081210
Commission Decision of 30 November 2007 approving annual and multi-annual national programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses, presented by the Member States for 2008 and following years (notified under document number C(2007) 5776) (2007/782/EC)
Consolidated text: Commission Decision of 30 November 2007 approving annual and multi-annual national programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses, presented by the Member States for 2008 and following years (notified under document number C(2007) 5776) (2007/782/EC)
Commission Decision of 30 November 2007 approving annual and multi-annual national programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses, presented by the Member States for 2008 and following years (notified under document number C(2007) 5776) (2007/782/EC)
02007D0782 — EN — 10.12.2008 — 001.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
COMMISSION DECISION of 30 November 2007 approving annual and multi-annual national programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses, presented by the Member States for 2008 and following years (notified under document number C(2007) 5776) (OJ L 314 1.12.2007, p. 29) |
Amended by:
|
|
Official Journal |
||
No |
page |
date |
||
L 331 |
15 |
10.12.2008 |
COMMISSION DECISION
of 30 November 2007
approving annual and multi-annual national programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses, presented by the Member States for 2008 and following years
(notified under document number C(2007) 5776)
(2007/782/EC)
CHAPTER I
ANNUAL PROGRAMMES
Article 1
Bovine brucellosis
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests, the compensation to owners for the value of their animals slaughtered subject to those programmes and the purchase of vaccine doses, and shall not exceed:
EUR 1 550 000 for Ireland;
EUR 3 000 000 for Spain;
EUR 4 100 000 for Italy;
EUR 15 000 for Cyprus;
EUR 1 460 000 for Portugal;
EUR 4 400 000 for the United Kingdom.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a rose bengal test |
EUR 0,2 per test; |
for a SAT test |
EUR 0,2 per test; |
for a complement fixation test |
EUR 0,4 per test; |
for an ELISA test |
EUR 1 per test. |
Article 2
Bovine tuberculosis
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin tests, laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
EUR 24 000 for Estonia;
►M1 EUR 7 700 000 ◄ for Spain;
EUR 2 700 000 for Italy;
►M1 EUR 1 500 000 ◄ for Poland;
EUR 347 000 for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a tuberculin test |
EUR 1 per test; |
for a gamma-interferon test |
EUR 5 per test. |
Article 3
Ovine and caprine brucellosis
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of carrying out laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
EUR 4 400 000 for Spain;
EUR 3 500 000 for Italy;
EUR 93 000 for Cyprus;
EUR 1 100 000 for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a rose bengal test |
EUR 0,2 per test; |
for a complement fixation test |
EUR 0,4 per test. |
Article 4
Bluetongue in endemic or high risk areas
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines, and shall not exceed:
►M1 EUR 630 000 ◄ for Belgium;
EUR 5 400 for Bulgaria;
►M1 EUR 1 200 000 ◄ for Germany;
EUR 100 000 for Greece;
►M1 EUR 5 800 000 ◄ for Spain;
►M1 EUR 3 100 000 ◄ for France;
EUR 1 300 000 for Italy;
EUR 70 000 for Luxemburg;
►M1 EUR 125 000 ◄ for the Netherlands;
EUR 245 000 for Austria;
►M1 EUR 610 000 ◄ for Portugal;
►M1 EUR 100 000 ◄ for Romania;
EUR 61 000 for Slovenia.
Article 5
Salmonellosis (zoonotic salmonella) in breeding flocks of Gallus gallus
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, the compensation to owners for the value of the birds culled, the destruction of eggs and the purchase of vaccine doses and shall not exceed:
►M1 EUR 700 000 ◄ for Belgium;
EUR 10 000 for Bulgaria;
►M1 EUR 500 000 ◄ for the Czech Republic;
EUR 75 000 for Denmark;
►M1 EUR 50 000 ◄ for Germany;
EUR 120 000 for Ireland;
EUR 150 000 for Greece;
EUR 800 000 for Spain;
►M1 EUR 400 000 ◄ for France;
►M1 EUR 120 000 ◄ for Italy;
EUR 45 000 for Cyprus;
EUR 60 000 for Latvia;
►M1 EUR 750 000 ◄ for Hungary;
►M1 EUR 1 000 000 ◄ for the Netherlands;
EUR 50 000 for Austria;
►M1 EUR 2 400 000 ◄ for Poland;
EUR 600 000 for Portugal;
►M1 EUR 10 000 ◄ for Romania;
EUR 275 000 for Slovakia.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a bacteriological test (cultivation) |
EUR 5,0 per test; |
for the purchase of one vaccine dose |
EUR 0,05 per dose; |
for serotyping of relevant isolates of Salmonella spp. |
EUR 20,0 per test. |
Article 6
Salmonellosis (zoonotic salmonella) in laying flocks of Gallus gallus
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, the compensation to owners for the value of the birds culled, the destruction of eggs and the purchase of vaccine doses, and shall not exceed:
►M1 EUR 500 000 ◄ for Belgium;
EUR 20 000 for Bulgaria;
EUR 1 000 000 for the Czech Republic;
►M1 EUR 250 000 ◄ for Germany;
EUR 20 000 for Estonia;
EUR 500 000 for Greece;
►M1 EUR 2 450 000 ◄ for Spain;
EUR 2 500 000 for France;
►M1 EUR 200 000 ◄ for Italy;
EUR 80 000 for Cyprus;
►M1 EUR 80 000 ◄ for Latvia;
EUR 10 000 for Luxembourg;
►M1 EUR 3 400 000 ◄ for Hungary;
EUR 2 000 000 for the Netherlands;
EUR 700 000 for Austria;
EUR 3 500 000 for Poland;
EUR 50 000 for Portugal;
EUR 20 000 for Romania;
EUR 500 000 for Slovakia;
EUR 80 000 for United Kingdom.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a bacteriological test (cultivation) |
EUR 5,0 per test; |
for the purchase of one vaccine dose |
EUR 0,05 per dose; |
for serotyping of relevant isolates of Salmonella spp. |
EUR 20,0 per test. |
Article 7
Classical swine fever and African swine fever
The programmes for the control and monitoring of:
Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2008 to 31 December 2008;
Classical swine fever and African swine fever submitted by Italy are hereby approved for the period from 1 January 2008 to 31 December 2008.
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out virological and serological tests of domestic pigs and wild boars and for the programmes submitted by Bulgaria, Germany, France, Romania and Slovakia also at the rate of 50 % of the costs to be incurred for the purchase and distribution of vaccines plus baits for the vaccination of wild boars, and shall not exceed:
EUR 400 000 for Bulgaria;
EUR 1 000 000 for Germany;
EUR 650 000 for France;
EUR 100 000 for Italy;
EUR 15 000 for Luxembourg;
►M1 EUR 2 000 000 ◄ for Romania;
EUR 40 000 for Slovenia;
►M1 EUR 375 000 ◄ for Slovakia.
Article 8
Swine vesicular disease
Article 9
Avian influenza in poultry and wild birds
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests and a lump sum for sampling of wild birds, and shall not exceed:
EUR 127 000 for Belgium;
EUR 76 000 for Bulgaria;
►M1 EUR 25 000 ◄ for the Czech Republic;
EUR 202 000 for Denmark;
►M1 EUR 280 000 ◄ for Germany;
EUR 8 000 for Estonia;
EUR 58 000 for Ireland;
EUR 72 000 for Greece;
EUR 306 000 for Spain;
EUR 155 000 for France;
►M1 EUR 600 000 ◄ for Italy;
EUR 15 000 for Cyprus;
EUR 33 000 for Latvia;
EUR 43 000 for Lithuania;
EUR 12 000 for Luxembourg;
EUR 184 000 for Hungary;
EUR 444 000 for the Netherlands;
EUR 55 000 for Austria;
EUR 81 000 for Poland;
EUR 165 000 for Portugal;
►M1 EUR 300 000 ◄ for Romania;
EUR 43 000 for Slovenia;
EUR 50 000 for Slovakia;
EUR 35 000 for Finland;
EUR 290 000 for Sweden;
EUR 400 000 for the United Kingdom.
The maximum amounts of the costs to be reimbursed to the Member States for the tests covered by the programmes shall not exceed:
ELISA test: |
EUR 1 per test; |
agar gel immune diffusion test: |
EUR 1,2 per test; |
HI test for H5/H7: |
EUR 12 per test; |
virus isolation test: |
EUR 30 per test; |
PCR test: |
EUR 15 per test; |
sampling wild birds |
EUR 20 per bird. |
Article 10
Transmissible spongiform encephalopathies (TSE)
The financial contribution by the Community shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for the implementation of those programmes, and shall not exceed:
EUR 1 950 000 for Belgium;
EUR 850 000 for Bulgaria;
EUR 950 000 for the Czech Republic;
EUR 1 600 000 for Denmark;
EUR 9 500 000 for Germany;
►M1 EUR 280 000 ◄ for Estonia;
►M1 EUR 6 200 000 ◄ for Ireland;
EUR 950 000 for Greece;
►M1 EUR 5 500 000 ◄ for Spain;
EUR 14 750 000 for France;
►M1 EUR 5 800 000 ◄ for Italy;
►M1 EUR 450 000 ◄ for Cyprus;
►M1 EUR 350 000 ◄ for Latvia;
EUR 550 000 for Lithuania;
EUR 150 000 for Luxembourg;
EUR 700 000 for Hungary;
EUR 37 000 for Malta;
►M1 EUR 2 950 000 ◄ for the Netherlands;
►M1 EUR 1 400 000 ◄ for Austria;
►M1 EUR 1 350 000 ◄ for Poland;
►M1 EUR 2 700 000 ◄ for Portugal;
►M1 EUR 1 000 000 ◄ for Romania;
EUR 200 000 for Slovenia;
►M1 EUR 550 000 ◄ for Slovakia;
►M1 EUR 550 000 ◄ for Finland;
►M1 EUR 1 500 000 ◄ for Sweden;
EUR 5 300 000 for the United Kingdom.
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be for the tests performed and the maximum amount shall not exceed:
EUR 5 per test, for tests carried out in bovine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 30 per test, for tests carried out in ovine and caprine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 50 per test, for tests carried out in cervid animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 175 per test, for primary molecular discriminatory tests carried out as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001.
Article 11
Bovine spongiform encephalopathy (BSE)
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 500 per animal, and shall not exceed:
EUR 50 000 for Belgium;
EUR 50 000 for Bulgaria;
EUR 150 000 for the Czech Republic;
EUR 50 000 for Denmark;
EUR 145 000 for Germany;
EUR 50 000 for Estonia;
►M1 EUR 130 000 ◄ for Ireland;
EUR 50 000 for Greece;
►M1 EUR 200 000 ◄ for Spain;
EUR 100 000 for France;
EUR 150 000 for Italy;
EUR 50 000 for Luxembourg;
EUR 50 000 for the Netherlands;
EUR 50 000 for Austria;
►M1 EUR 300 000 ◄ for Poland;
►M1 EUR 130 000 ◄ for Portugal;
EUR 10 000 for Slovenia;
EUR 125 000 for Slovakia;
EUR 25 000 for Finland;
EUR 176 000 for the United Kingdom.
Article 12
Scrapie
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost incurred by the concerned Member States for compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 100 per animal and at a rate of 50 % of the cost of the analysis of samples for genotyping, up to a maximum of EUR 10 per genotyping test, and shall not exceed:
EUR 66 000 for Belgium;
EUR 26 000 for Bulgaria;
EUR 88 000 for the Czech Republic;
►M1 EUR 110 000 ◄ for Denmark;
►M1 EUR 100 000 ◄ for Germany;
EUR 12 100 for Estonia;
►M1 EUR 250 000 ◄ for Ireland;
EUR 700 000 for Greece;
►M1 EUR 3 700 000 ◄ for Spain;
►M1 EUR 2 450 000 ◄ for France;
EUR 1 500 000 for Italy;
►M1 EUR 1 200 000 ◄ for Cyprus;
EUR 1 100 for Latvia;
EUR 3 000 for Lithuania;
EUR 27 000 for Luxembourg;
EUR 343 000 for Hungary;
►M1 EUR 150 000 ◄ for the Netherlands;
EUR 26 000 for Austria;
►M1 EUR 100 000 ◄ for Portugal;
►M1 EUR 100 000 ◄ for Romania;
EUR 61 000 for Slovenia;
►M1 EUR 100 000 ◄ for Slovakia;
►M1 EUR 50 000 ◄ for Finland;
►M1 EUR 1 800 000 ◄ for the United Kingdom.
Article 13
Rabies
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:
►M1 EUR 0 ◄ for Bulgaria;
EUR 700 000 for Lithuania;
EUR 1 000 000 for Hungary;
EUR 330 000 for Austria;
EUR 4 200 000 for Poland;
EUR 0 for Romania;
EUR 425 000 for Slovakia.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 8 per test; |
for a test to detect tetracycline in bone |
EUR 8 per test. |
Article 14
Enzootic bovine leucosis
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed EUR:
EUR 15 000 for Estonia;
EUR 200 000 for Lithuania;
EUR 3 000 000 for Poland.
The maximum amounts of the costs to be reimbursed to the Member States for the programme referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 0,5 per test; |
for an agar gel immune diffusion test |
EUR 0,5 per test. |
Article 15
Aujeszky’s disease
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:
EUR 450 000 for Spain;
EUR 60 000 for Hungary;
EUR 4 650 000 for Poland.
CHAPTER II
MULTI-ANNUAL PROGRAMMES
Article 16
Rabies
The multi-annual programmes for the eradication of rabies submitted by the Czech Republic, Germany, Estonia, Latvia, Slovenia, and Finland are hereby approved for the period from:
1 January 2008 to 31 December 2009 for the Czech Republic and Germany;
1 January 2008 to 31 December 2010 for Latvia and Finland;
1 January 2008 to 31 December 2011 for Estonia;
1 January 2008 to 31 December 2012 for Slovenia.
The maximum amounts of the costs to be reimbursed to the concerned Member State for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 8 per test; |
for a test to detect tetracycline in bone |
EUR 8 per test. |
The contribution to cover the period for the implement of the multi-annual programmes shall not exceed:
EUR 1 000 000 for the Czech Republic;
EUR 800 000 for Germany;
EUR 4 750 000 for Estonia;
EUR 3 700 000 for Latvia;
EUR 1 750 000 for Slovenia;
EUR 300 000 for Finland.
The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2008. An indication of these amounts (in euro) is given below:
Member state |
2009 |
2010 |
2011 |
2012 |
Czech republic |
500 000 |
|
|
|
Germany |
325 000 |
|
|
|
Latvia |
1 250 000 |
1 250 000 |
|
|
Finland |
100 000 |
100 000 |
|
|
Estonia |
1 250 000 |
1 250 000 |
1 250 000 |
|
Slovenia |
350 000 |
350 000 |
350 000 |
350 000 |
Article 17
Aujeszky’s disease
Article 18
Enzootic bovine leucosis
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 0,5 per test; |
for an agar gel immune diffusion test |
EUR 0,5 per test. |
The contribution to cover the period for the implementation of the multi-annual programmes shall not exceed:
EUR 2 000 000 for Italy;
EUR 170 000 for Latvia;
EUR 1 000 000 for Portugal.
The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2008. An indication of these amounts (in euro) is given below:
Member state |
2009 |
2010 |
2011 |
2012 |
Italy |
800 000 |
800 000 |
|
|
Latvia |
55 000 |
55 000 |
|
|
Portugal |
350 000 |
350 000 |
|
|
CHAPTER III
GENERAL AND FINAL PROVISIONS
Article 19
The average compensation to be reimbursed to the Member States shall be calculated on the basis of the number of animals slaughtered or culled in the Member State and:
for bovine animals, up to a maximum of |
EUR 375 per animal; |
for sheep and goats, up to a maximum of |
EUR 50 per animal; |
for breeding bird of Gallus gallus, up to a maximum of |
EUR 3,5 per bird; |
for laying bird of Gallus gallus, up to a maximum of |
EUR 1,5 per bird. |
Article 20
Article 21
The financial contribution by the Community for the programmes referred to in Articles 1 to 18 shall be granted provided that the Member States concerned:
implement the programmes in accordance with the relevant provisions of Community law, including rules on competition and on the award of public contracts;
bring into force by 1 January 2008 at the latest the laws, regulations and administrative provisions necessary for implementing the programmes referred to in Articles 1 to 18;
forward to the Commission by 1 June 2008 at the latest the intermediate technical and financial reports for the programmes referred to in Articles 1 to 18, in accordance with Article 24(7) (a) of Decision 90/424/EEC;
for the programmes referred to in Article 9, report to the Commission the positive and negative results of investigations detected during their surveillance of poultry and wild birds through the Commission on-line system every three months by forwarding within a period of four weeks following the end of the month covered by the report;
for the programmes referred to in Articles 10 to 12, forward a report to the Commission every month on the results of the TSE monitoring programme by forwarding within a period of four weeks following the end of the month covered by the report;
for the programmes referred to in Articles 1 to 18, forward a final report to the Commission in accordance with Article 24(7)(b) of Decision 90/424/EEC by 30 April 2009 at the latest on the technical execution of the programme accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2008 to 31 December 2008;
for programmes referred to in Articles 1 to 18, implement the programme efficiently;
do not for the programmes referred to in Articles 1 to 18, submit further requests for other Community contributions for these measures, and have not previously submitted such requests.
Article 22
This Decision shall apply from 1 January 2008.
Article 23
This Decision is addressed to the Member States.
( 1 ) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation (EC) No 1791/2006 (OJ L 363, 20.12.2006, p. 1).
( 2 ) OJ L 397, 30.12.2006, p. 22.
( 3 ) OJ L 347, 12.12.1990, p. 27. Decision as amended by Directive 92/65/EEC (OJ L 268, 14.9.1992, p. 54).
( 4 ) OJ L 147, 31.5.2001, p. 1. Regulation as last amended by Commission Regulation (EC) No 727/2007 (OJ L 165, 27.6.2007, p. 8).
( 5 ) OJ L 10, 14.1.2006, p. 16.
( 6 ) OJ L 248, 16.9.2002, p. 12.
( 7 ) OJ L 209, 11.8.2005, p. 1. Regulation as last amended by Regulation (EC) No 378/2007 (OJ L 95, 5.4.2007, p. 1).